Release of endogenous opioids during a chronic IBD model suppresses the excitability of colonic DRG neurons

Background  Endogenous opioids are implicated in pain‐regulation in chronic inflammatory bowel disease (IBD). We sought to examine whether endogenous opioids suppress the excitability of colonic nociceptive dorsal root ganglia (DRG) neurons during chronic IBD, and if so, whether modulation of underl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurogastroenterology and motility 2013-01, Vol.25 (1), p.39-e4
Hauptverfasser: Valdez‐Morales, E., Guerrero‐Alba, R., Ochoa‐Cortes, F., Benson, J., Spreadbury, I., Hurlbut, D., Miranda‐Morales, M., Lomax, A. E., Vanner, S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background  Endogenous opioids are implicated in pain‐regulation in chronic inflammatory bowel disease (IBD). We sought to examine whether endogenous opioids suppress the excitability of colonic nociceptive dorsal root ganglia (DRG) neurons during chronic IBD, and if so, whether modulation of underlying voltage‐gated K+ currents was involved. Methods  The effects of chronic dextran sulfate sodium (DSS) colitis on afferent signaling in mice was studied using patch clamp recordings. Colonic DRG neurons were identified using Fast Blue retrograde labeling and recordings obtained from small DRG neurons (
ISSN:1350-1925
1365-2982
DOI:10.1111/nmo.12008